Larvol Delta - A-Phase-12-Study-to-Evaluate-CHM2101-an-Autologous-Cadherin-17-Chimeric-Antigen-Receptor-CAR-T-Cell-Therapy

CHM 2101 - Chimeric Therap

http://clinicaltrials.gov/ct2/show/NCT06055439

Sep 26, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next